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Edited by Laszlo NagyAbstract A tight hormonal control of energy homeostasis is of
pivotal relevance for animals. Recent evidence suggests an
involvement of the nuclear receptor NR1i3 (CAR). Fasting in-
duces CAR by largely unknown mechanisms and CAR-deﬁcient
mice are defective in fasting adaptation. In rat hepatocytes CAR
was induced by WY14643, a PPARa-agonist. A DR1 motif in
the CAR promoter was necessary and suﬃcient for this control.
The PPARa-dependent increase in CAR potentiated the pheno-
barbital-induced transcription of the prototypical CAR-depen-
dent gene CYP2B1. Since free fatty acids are natural ligands
for PPARa, a fasting-induced increase in free fatty acids might
induce CAR. In accordance with this hypothesis, CAR induction
by fasting was abrogated in PPARa-deﬁcient mice.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A stringent control of energy homeostasis is of pivotal rele-
vance in animals and humans. Excess in either energy expendi-
ture or intake in the long run leads to diseases like cachexia or
obesity with metabolic syndrome and type 2 diabetes, respec-
tively [1,2]. Therefore, complex control mechanisms have
evolved that adjust food intake to the actual demands. In addi-
tion, a healthy organism can adapt energy expenditure to vari-
ations in fuel supply over a wide range. Thus, resting energy
expenditure increases when food supply is ample whereas it
decreases upon starvation. To achieve this high level of ﬂexibil-
ity metabolic pathways that inﬂuence energy expenditure are
under tight hormonal control. In this respect, thyroid hor-
mones are of outstanding importance. The abundance of the
active form of thyroid hormone, T3, is controlled in a dual
way: Synthesis and liberation of both T3 and the less active*Corresponding author. Fax: +49 33200 88 541.
E-mail address: gpuesche@rz.uni-potsdam.de (G.P. Pu¨schel).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.11.011T4 from the thyroid gland is stimulated by TSH, whose release
is controlled by the hypothalamus-pituitary axis and is inhib-
ited by thyroid hormones in a negative feedback inhibition
loop. Apart from this, regulated processing and elimination
of thyroid hormones provides an additional level of control.
The majority of T3 in the circulation is derived from deiodin-
ation of the outer ring of its precursor T4 in the liver. Modiﬁ-
cation of thyroid hormones by enzymes of the xenobiotic
metabolism (sulfotransferases, UDP-glucuronosyltransferases,
multi drug resistance associated proteins) prevents this activa-
tion step and in addition leads to the inactivation and elimina-
tion of T3 [3,4]. The transcription of genes coding for proteins
involved in the inactivation of thyroid hormone is under the
control of the nuclear receptor NR1i3 (CAR, constitutive
androstane receptor). In particular, induction of hepatic xeno-
biotic-metabolizing and thyroid hormone-metabolizing en-
zymes by phenobarbital is mediated by CAR. Recently, it
has been shown that CAR and as a consequence thyroid hor-
mone-inactivating enzymes were also induced by starvation [5].
In addition, mice lacking the CAR gene showed a severely im-
paired fasting tolerance. These results clearly indicate that
CAR is a central player in the adaptation of energy homeosta-
sis to reduced fuel supply. The mechanisms by which fasting
induces CAR expression are, however, largely unknown. A re-
cent publication provides evidence that a fasting-induced in-
crease in plasma adrenalin leads to a cAMP-mediated
induction of PGC1a which in turn enhances the HNF4a-
dependent transcription of the CAR gene [6]. CAR in cooper-
ation with PGC1a then enhances the transcription of CAR
target genes. The mechanism proposed in this study can, how-
ever, explain only part of the fasting-induced CAR expression
since fasting-dependent CAR induction was retained to a cer-
tain extent in HNF4a-deﬁcient mice. In addition, excessively
high adrenaline concentrations (100 lM) that never can be
achieved in vivo were employed in this study to evoke the ob-
served eﬀects in cell culture experiments. Therefore, we sought
for an alternative mechanism by which starvation can lead to
an induction of CAR. A hallmark of fasting adaptation is
the increase in plasma free fatty acids. Free fatty acids are
ligands for the nuclear receptor PPARa [7]. We therefore ana-
lyzed whether PPARa activation enhanced CAR expression
and modulated the expression of a CAR target gene. It wasblished by Elsevier B.V. All rights reserved.
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expression and potentiated the phenobarbital-dependent
induction of the typical CAR target gene CYP2B1 in primary
cultures of rat hepatocytes or in vivo after treatment of rats
with Phenobarbital and WY14643. In line with our hypothesis,
fasting-dependent induction of CAR expression was impaired
in PPARa-null mice.2. Materials and Methods
2.1. Materials
All chemicals were purchased from commercial sources indicated
throughout the text. Oligonucleotides were custom-synthesized by
MWG Biotech AG (Ebersberg, Germany) and Sigma/Genosys (Stein-
heim, Germany). The pGL3 constructs pGL3C2B1, pGL3CD2 and
pGL3CD8 were kindly provided by Bauer [8].
2.2. Animals
Male Wistar rats (200–300 g) were purchased from Charles River
(Sulzfeld, Germany) and kept on a 12 h day/night rhythm (light from
06:00 to18:00 h) with free access to water and the standard rat diet
1320 (altromin, Gesellschaft fu¨r Tierhaltung, Lage, Germany).
Male pure-bred Sv129 and PPARa-null mice on a Sv129 back-
ground were used at 3–5 months of age (Jackson Laboratories, Bar
Harbor, ME). Animals were kept on a 12 h day/night cycle with free
access to normal laboratory chow (RMH-B diet, Arie Blok animal
feed, Woerden, the Netherlands).
Treatment of the animals followed the German and the Netherlands
Law on the Protection of Animals and was performed with permission
of the state animal welfare committees.
2.3. Animal experiments
For three consecutive days male Wistar rats (3 in each group) were
injected either vehicle (saline) or 3.13 mg PB/kg BW. The last day the
PB was administered alone or together with a single dose of 50 mg WY
14643/kg BW or vehicle (equal parts of DMSO and saline). The fol-
lowing day livers were removed from anesthetized rats (ether). Livers
were homogenized in 3 ml KBS buﬀer (10 mM Na2HPO4, 10 mM
NaH2PO4, 110 mM KCl, pH 7.4)/g liver, containing 5 mM EDTA,
50 mM NaF and 200 lM pefabloc and 10 lg/ml trypsin inhibitor.
Microsomes were prepared immediately by diﬀerential centrifugation
and the CYP2B-catalyzed O-depentylation of 7-pentoxyresoruﬁn was
measured ﬂuorometrically (see below). Fed mice were killed at the
end of the dark cycle. Fasting was started at the onset of the light cycle
for the times indicated. Mice were killed by cervical dislocation. Livers
were isolated and frozen immediately for later RNA quantiﬁcation.
2.4. Hepatocyte preparation and culture
Rat hepatocytes were isolated as described previously [9]. Hepato-
cytes (1.2 · 105 cells/cm2) were plated on plastic tissue culture plates
(Sarstedt, Nu¨rnbrecht, Germany) in Williams E medium containing
0.5 nM insulin, 100 nM dexamethasone (all Sigma–Aldrich, Deisenho-
fen, Germany), 10 mg/ml penicillin/streptomycin (Biochrom, Berlin,
Germany) and for the ﬁrst 4 h of culture 4% newborn calf serumTable 1
Sequences of the primers used to generate reporter gene constructs
Primer
rCARprom_R
+rCARprom_F1.9
+rCARprom_F2.6
+rCARprom_F4.4
rCARprom_DDR1d_R
rCARprom_DDR1d_F
rCARprom_DDR1c_R
rCARprom_DDR1c_F
rCARprom_DDR1p_R
rCARprom_DDR1p_F(v/v) (Biochrom, Berlin, Germany). Culture was then continued in ser-
um free medium at 37 C in a humidiﬁed atmosphere of 5% CO2 and
95% air. Medium was supplemented with ITS (insulin 5 mg/L, transfer-
rin 5 mg/L, sodium selenite 5 lg/L) (Sigma–Aldrich, Deisenhofen, Ger-
many) as noted. The medium was replaced daily. At the time indicated
1 mM phenobarbital and/or 10 lM WY 14643 or the solvent 0.1%
DMSO were added and the culture was continued for a total of
72 h. Hepatocytes were washed twice with PBS (137 mM NaCl,
2.7 mM KCl, 1.5 mM KH2PO4, Na2HPO4 Æ 2H2O, pH 7.3), shock fro-
zen in N2 and stored at 70 C for subsequent analysis.
2.5. Generation of the CAR promoter constructs and PPARa expression
plasmids
Fragments containing 4.4 kb, 2.6 kb or 1.9 kb of the CAR promoter
were generated from rat genomic DNA by PCR using the primers
listed in Table 1, then blunt-end ligated into pJet and subcloned in
the right direction into pGL3basic (Promega, Mannheim, Germany).
Starting from a vector containing the 1.9 kb promoter fragment addi-
tional shorter fragments were generated using unique restriction sites
or PCR-based site-directed mutagenesis. The translated region of the
rat PPARa gene was ampliﬁed by PCR from hepatocyte cDNA with
proofreading thermostable polymerase. The PCR-fragment was cloned
into the expression vector pcDNA3.
2.6. Cell transfection and luciferase reporter gene assay
Primary adherent rat hepatocyte cultures, plated onto plastic 3.5 cm
diameter tissue culture plates (0.7 · 106 cells/plate), were transiently
transfected immediately after seeding with 1 lg of each pGL3-derived
plasmid using a modiﬁed calcium phosphate transfection protocol
described previously [10]. Afterwards the hepatocytes were treated as
described above. At the end of the experiment at 72 h of cell culture
hepatocytes were lysed in 100 ll of luciferase cell culture lysis reagent
(Promega) and ﬁreﬂy luciferase activity was measured in 25 ll of cell
lysate using the Fluostar Optima (BMG Labtech, Oﬀenburg,
Germany). HEK293-cells were transiently transfected with the pcDNA
expression vector constructs as described previously [11].
2.7. Microsome preparation
Hepatocytes were scraped into 100 ll KBS buﬀer (10 mM Na2H-
PO4, 10 mM NaH2PO4, 110 mM KCl, pH 7.4) per 3.5 cm diameter
plate, containing 5 mM EDTA, 50 mM NaF and 200 lM pefabloc,
10 lg/ml leupeptin and 10 lg/ml trypsin inhibitor. Suspensions were
then soniﬁed. The cell homogenates were centrifuged for 10 min at
2500 · g and the supernatants were centrifuged further for 120 min
at 36700 · g. The pellets were then resuspended in 100 mM potassium
phosphate buﬀer pH 7.4, containing 1 mM EDTA, 5 mM NaF and
20% glycerol and shock frozen in N2 and stored at 70 C. Prior to
further use protein content was determined [12].
2.8. Cell lysate preparation
Hepatocytes were scraped into 100 ll lysis buﬀer per 3.5 cm diameter
plate (20 mM Tris/Hcl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Tri-
ton X-100, 2.5 mM Na4P2O7, b-glycerol phosphate 50 mM NaF,
200 lM pefabloc, 10 lg/ml leupeptin and 10 lg/ml trypsin inhibitor).
Suspensions were then soniﬁed. The cell homogenates were centrifuged
for 15 min at 10000 · g. The collected supernatant was stored at
20 C. Prior to further use protein content was determined [12].Sequence
5 0-CAGGAATTAGGGATTGTGGTCCTC-30
5 0-CAGAGTGATGAAGACAGAGCTTGG-30
5 0-CGCAGTAGCAAGCAAACTAGAGTAG-30
5 0-CAGAGTGATGAAGACAGAGCTTGG-30
5 0-GCCGCCcgatcgGTTAAGCCGTGGCGGCTCGATC-30
5 0-GCCGCCcgatcgGAACTGCTGATTTCCAGAC-3 0
5 0-GCCGCCcgatcgCACACTCAGTGGCTCATTGG-3 0
5 0-GCCGCCcgatcgGTGGATTCCAGGGGTCAAAG-3 0
5 0-GCGGCGcgatcgCTGTCTGATATTCTGGGGCTAGAG -3 0
5 0-GCGGCGcgatcgCTGTGGGTACTAGGTGTACACATT-30
Fig. 1. Attenuation of fasting-dependent CAR induction in PPARa-
deﬁcient mice. Control or PPARa-deﬁcient mice were starved for the
times indicated. CAR mRNA levels were determined by qPCR in livers
of these animals. Statistics: Student’s t-test; (a) signiﬁcantly diﬀerent
from control mice, P < 0.05, n = 5.
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Pentoxyresoruﬁn O-dealkylation activity was measured by direct
ﬂuorometric detection of resoruﬁn formation [13]. Brieﬂy, dealkylation
activity of 5 lg of protein was measured in 200 ll of a 50 mM potas-
sium phosphate buﬀer pH 7.4, containing 4.5 lM 7-pentoxyresoruﬁn,
65 lM NADP+, 165 lM glucose-6-phosphate, 165 lM MgCl2 Æ 6 H2O
and 0.4 U glucose-6-phosphate dehydrogenase (all Sigma–Aldrich,
Deisenhofen, Germany) over a period of 20 min. The reaction rate
was determined by external calibration with solutions of known res-
oruﬁn concentrations.
2.10. Immunoblotting protein
Hepatic microsomes, cell lysates (CYP2B, 50 lg of protein) or nucle-
ar extracts (30 lg of protein) were subjected to SDS–PAGE. After
electrotransfer onto polyvinylidene diﬂuoride membrane (Roth,
Karlsruhe, Germany), blots were blocked with Tris-buﬀered saline
containing 0.10% Tween and 5% dry milk for 1 h at room temperature
and incubated overnight at 4 C with a mouse monoclonal antibody
against rat liver CYP2B (Oxford Biomedical Research, Oxford MI,
USA), a rabbit polyclonal antibody against mouse CAR (Axxora Deu-
tschland GmbH, Gru¨nberg, Germany) or a rabbit polyclonal antibody
against PPARa (Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA). Immune complexes were detected using horseradish peroxi-
dase-linked goat anti-mouse IgG or goat anti-rabbit IgG according
to the ECL Plus Western blotting kit (Amersham Pharmacia Biotech.).
Immunoreactive bands were visualized and quantiﬁed by using the
imaging system QuantityOne (Biorad).
2.11. RNA preparation and Northern blot analysis
Total RNA was isolated from hepatocyte cultures by guanidinium
thiocyanate phenol extraction, [14] subjected to electrophoresis on
formaldehyde-agarose gels, and subsequently transferred to Hybond-
N nylon membranes as described previously [15]. RNA blots were
hybridized to the oligonucleotide probe 5 0-GGTTGGTAGCCGG-
TGTGA-3 0 speciﬁc for the rat CYP2B1 gene (bases 49–66 of exon 7
region; Genebank L00318) which had been 5 0end-labeled by T4-poly-
nucleotide kinase utilizing [c-32P] ATP [16] RNA expression was quan-
tiﬁed by an imaging system (Fujix BAS 1500 Bio-Imaging Analyzer,
Fujix, Tokio, Japan). Control hybridizations were performed using a
GAPDH antisense oligonucleotide probe [17].
2.12. Real-time RT-PCR
RNA was isolated using the SV total RNA kit (Promega). To gen-
erate standards for CAR and b-actin RT-PCR using the oligonucleo-
tides listed below was carried out with hepatocyte cDNA as template
and the resulting fragments were cloned blunt end into pJET or
pUC57 (both MBI-Fermentas). Hot start real-time PCR for the quan-
tiﬁcation of each transcript was carried out in a reaction mixture of
15 lL of iQ SYBR Green Supermix (Bio-Rad, Mu¨nchen) and 5 lL
of cDNA. PCR was performed with an initial enzyme activation step
at 95 C for 3 min. Followed by 40 cycles of denaturation at 95 C
for 30 s, annealing at 63 C for 30 s and extension at 72 C for 1 min
in a real-time DNA thermal cycler (iCyclerTM, Bio-Rad). The
following oligonucleotides where used as forward and reverse
primers respectively: 5 0-TCTCACTCAACACTACGTTC-30 and
5 0-CTGGAAAAGGATCCAAGCCTGGG-3 0 for CAR [18] and 5 0-
CCCTAAGGCCAACCGTGAAAAGATG-3 0 and 5 0-AGGTCCCG-
GCCAGCCAGGTCCAG-3 0 for b-actin. The initial copy number of
the ampliﬁed cDNA was quantitated by determining the number of cy-
cles required to raise the ﬂuorescence signal above a deﬁned threshold
during the logarithmic phase of ampliﬁcation. Using the respective
standard curves the copy numbers were calculated. The results are
shown relatively to the control level after normalization to that of
b-actin.
2.13. Electrophoretic mobility shift assay
The electrophoretic mobility shift assay was performed essentially as
described previously [8]. Nuclear extracts were prepared from hepato-
cytes which were kept in culture for 72 h as described above. Alterna-
tively, nuclear extracts were prepared from HEK293-cells that had
been transiently transfected with either pcDNA3 or pcDNA3-ratP-
PARa. A double stranded oligonucleotide probe was generated by
hybridizing 5 0-GAGTGTGTATAAAGGTCAGAGAACAACCTG
and 5 0-GGCCCCTGCAGGTTGTTCTCTGACCTTTATA whichcontain the sequence of the central DR1-motif of the rat CAR pro-
moter (bold). The 5 0-overhangs were ﬁlled with a Klenow reaction
mix containing a[32P]dCTP. Binding of 5 lg nuclear extract protein
to 0.2 lCi (0.5 pmol) probe was performed in presence of 2 lg of unre-
lated DNA (pGL-basic) to avoid unspeciﬁc binding. Binding was com-
peted with a about 100-fold excess of unlabelled probe or a 5-fold
molar excess of plasmids containing the wild-type or mutated 1.9 kb
promoter fragments as indicated.3. Results and discussion
3.1. PPARa-dependent induction of CAR in the adaptive
response to fasting
As reported previously by others, CAR mRNA was induced
about 4-fold in livers of rats starved for 24 h (see supplemen-
tary material). Similarly, CAR mRNA was induced about
2,5-fold after a 12 h to 24 h fast in wild-type Sv129 mice
(Fig. 1). Since, among other mechanisms, the activation of
the nuclear receptor PPARa during caloric restriction regu-
lates the adaptive response of the energy metabolism [19,20],
it was hypothesized that PPARa might also play a role in
the fasting-dependent induction of CAR. In line with this
hypothesis the fasting-dependent induction of CAR mRNA
observed in wild-type mice was signiﬁcantly reduced in
PPARa-deﬁcient mice, indicating that a functional PPARa is
essential for the induction of CAR by fasting. Further support-
ing this hypothesis, CAR mRNA was also induced about 1.5-
fold by intraperitoneal injection of the PPARa-speciﬁc agonist
WY14643 in rats (Fig. 2A).
3.2. Potentiation of the induction of the CAR target gene
CYP2B1 by PPARa agonists
To analyze whether the PPARa-dependent increase in CAR
was functionally relevant the impact of a PPARa agonist on a
prototypic CAR-dependent gene whose transcription, unlike
that of for instance UGT1A1, was not aﬀected by the PPARa
agonist itself was analyzed. Rat CYP2B1 appeared to fulﬁll
these requirements. CYP2B1 activity was almost not detect-
able in livers of control rats (Fig. 2B). Activity was induced
by a low dose of phenobarbital (3.13 mg/kg body weight) to
about 6 lU/mg. This induction was enhanced about 4-fold
Fig. 2. PPARa-dependent induction of CAR an potentiation of phenobarbital-induced CYP2B expression in rats in vivo. Male wistar rats (200–
300 g) were injected vehicle (saline) or 3.13 mg PB/kg BW for three consecutive days. The last day the PB was administered either alone or together
with a single dose of 50 mg WY 14643/kg BW or vehicle (a mixture of equal volumes of DMSO and saline). The following day livers were removed
from anesthetized rats (ether). RNA or microsomes were isolated. CAR mRNA was quantiﬁed by real-time PCR as described in the methods section,
CYP2B activity was determined as described in legend to Fig. 2. Values are means ± S.E.M. of n P 3 independent experiments. Statistics: Student’s
t-test for paired samples: (a) signiﬁcantly higher than control, P < 0.05 and (b) signiﬁcantly higher than phenobarbital-stimulated, P < 0.05.
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WY14643 which induced CAR mRNA (Fig. 2A) but did not
aﬀect CYP2B1 activity by itself (Fig. 2B). Phenobarbital did
not alter CAR expression signiﬁcantly (Fig. 2A).
To further analyze the PPARa agonist-dependent increase
of CYP2B1 primary cultures of rat hepatocytes were incubated
with the PPARa-selective agonist WY14643 for 24 h and with
phenobarbital for 48 h as indicated (Fig. 3). Like in the liver of
PPARa agonist treated or fasted rats CAR mRNA was in-
creased about 3-fold in hepatocytes treated with the PPARa
agonist. In hepatocyte cultures kept in the presence of WY
14643 plus phenobarbital CAR mRNA-level was elevated
about 10-fold over the basal level. Apparently, phenobarbital
potentiated the PPARa-dependent CAR mRNA induction;
yet phenobarbital by itself did not signiﬁcantly augment the
CAR mRNA levels. The induction of CAR by WY 14643
but not the potentiation of this induction by phenobarbital
was also seen on the protein level by Western blot analysis
(Fig. 3, bottom). The CAR target gene CYP2B1 was almost
not detectable in untreated rat hepatocytes, neither by mea-
surement of the enzyme activity nor by Western blot analysisor on the mRNA-level by Northern blot analysis (Fig. 4). As
seen in vivo, CYP2B1 was induced by treatment of hepatocytes
with phenobarbital for 48 h. This induction was enhanced
about 2-fold by the simultaneous presence of the PPARa ago-
nist for 24 h. However, the PPARa agonist by itself did not in-
duce CYP2B1, clearly indicating that the PPARa eﬀect on
CYP2B expression was indirect, and most probably via the
induction of CAR.
To further corroborate the hypothesis that CAR-induction
is a prerequisite for the potentiation of phenobarbital-induced
CYP2B activity by the PPARa agonist, the transcription of a
luciferase reporter gene construct under the control of a frag-
ment of the CYP2B1 promoter was analyzed in primary hepa-
tocyte cultures. In accordance with the protein and mRNA
data, transcription of the reporter gene containing part of
the wild-type CYP2B1 promoter (pGL3C2B1) was increased
by phenobarbital (Fig. 5). This increase was further enhanced
by the simultaneous presence of the PPARa agonist, which, at
variance with the protein and mRNA data, also by itself in-
creased the transcription of the reporter gene. This discrepancy
might be attributable to additional posttranscriptional control
Fig. 3. Induction by WY14643 of CAR in rat hepatocytes. Primary
cultures of rat hepatocytes were cultured as described in materials and
methods. Phenobarbital and the PPARa agonist WY14643 were added
as indicated after 24 h and 48 h of culture, respectively. After a total
culture period of 72 h hepatocytes were harvested, mRNA was
extracted by aﬃnity chromatography and quantiﬁed by real-time
RT-PCR. The copy number was normalized to the copy number of
GAPDH-mRNA. Values are means ± S.E.M. of n P 3 independent
experiments. Statistics: Student’s t-test for paired samples: (a) signif-
icantly higher than control, P < 0.05 and (b) signiﬁcantly higher than
phenobarbital-stimulated, P < 0.05. CAR protein was detected by
western blot with a polyclonal antibody against a conserved peptide
between mouse and rat CAR. A representative blot of three similar
independent experiments is shown.
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mRNA stability or translation. Evidence that CYP2B1 mRNA
abundance is regulated on the posttranscriptional level was
recently provided [21]. The synthesis of functional CYP2B
protein also depends on the adequate supply with heme
whose synthesis is controlled by amino levulinate synthase 1
(ALAS-1) an enzyme that is induced by phenobarbital in aFig. 4. Potentiation by WY14643 of the phenobarbital-dependent induction o
section. Phenobarbital and the PPARa agonist WY14643 were added as ind
period of 72 h hepatocytes were harvested. Cyp2B activity and protein were d
assay and Western blot, respectively. mRNA was determined by Northern
means ± S.E.M. of n P 3 independent experiments. Statistics: Student’s t-tes
(b) signiﬁcantly higher than phenobarbital-stimulated, P < 0.05.CAR-independent manner [22]. To distinguish a possible
CAR-independent PPARa eﬀect on the CYP2B1 promoter
from an eﬀect that is dependent on a prior induction of
CAR, additional reporter gene constructs were employed: In
a reporter gene construct lacking the phenobarbital-responsive
enhancer module (PBREM, nucleotides 2626 to 2156),
which contains the presumed CAR binding site, phenobarbi-
tal, as expected, did no longer increase the reporter gene activ-
ity (pGL3CD8), whereas the induction of the reporter gene by
the WY14643 was preserved in this construct (Fig. 5). By con-
trast, a reporter gene construct lacking a 178 bp fragment in
the proximal promoter region (nucleotides 353 to 176,
pGL3CD2) was no longer directly activated by the PPARa
agonist, however, it retained the full response to phenobarbital
and displayed a similar potentiation of the phenobarbital-
dependent induction by WY14643 as the wild-type promoter
(Fig. 5). Thus, this construct behaved as expected for an ideal
probe that is not directly activated by PPARa but senses the
PPARa-dependent induction of CAR. PPARa may stimulate
CYP2B1 promoter activity directly as well as indirectly via a
mechanism involving CAR. These two eﬀects are mediated
by distinct regions within the CYP2B1 promoter. These data
furthermore suggest that the induction of CAR by the PPARa
agonist might be relevant for the control of the transcription of
other CAR-dependent genes.
3.3. Characterization of the CAR promoter
To gain further insight into the mechanisms by which the
PPARa agonist increased CAR mRNA, reporter gene con-
structs were generated that express the luciferase gene under
the control of the rat CAR promoter. Luciferase transcription
was increased by the PPARa agonist WY14643 in constructs
containing 4.4, 2.6 or 1.9 kb of the rat CAR promoter whereas
luciferase transcription was not aﬀected by the PPARa agonist
in the control vector (Fig. 6). Phenobarbital did not inﬂuence
the basal transcription rate in any of the constructs. At variance
to what was seen on the mRNA level (Fig. 3), phenobarbitalf CYP 2B1. Rat hepatocytes were cultured as described in the methods
icated after 24 h and 48 h of culture, respectively. After a total culture
etermined in a microsomal fraction by a pentoxyresoruﬁn-depentylaton
blot. Band intensities were quantiﬁed densitometrically. Values are
t for paired samples: (a) signiﬁcantly higher than control, P < 0.05 and
Fig. 5. CAR-dependent potentiation of the phenobarbital-induced expression of a reporter gene under the control of the CYP2B1 promoter by
WY14643. Hepatocytes were cultured as described in the methods section. Immediately after seeding they were transfected with the reporter gene
constructs by a modiﬁed calcium phosphate method. Phenobarbital and the PPARa agonist WY14643 were added as indicated after 24 h and 48 h of
culture, respectively. After a total culture period of 72 h hepatocytes were harvested. Luciferase activity was determined in cell lysates. Values are
means ± S.E.M. of n P 3 independent experiments. Statistics: Student’s t-test for paired samples: (a) signiﬁcantly higher than control, P < 0.05 and
(b) signiﬁcantly higher than phenobarbital-stimulated, P < 0.05.
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crease in CAR transcription, indicating that the phenobarbital-
dependent potentiation of the PPARa-elicited increase in
mRNA occurred on a posttranscriptional level possibly by sta-
bilizing CAR mRNA. In this context it is worth noting, that
phenobarbital has been shown to unspeciﬁcally stabilize
mRNAs [23]. However, the phenobarbital-dependent increase
of CAR mRNA was not reﬂected on the protein level (Fig. 3,
bottom). On the protein level, phenobarbital rather reduced
the PPARa-induced CAR expression slightly. The pattern of
CAR induction on the protein level thus is in better agreement
with the CAR promoter studies than the induction on the
mRNA level.
Computer analysis of the 1.9 kb CAR promoter fragment
identiﬁed three DR1 (direct repeats separated by 1 nucleotide)
motifs which are potential PPARa binding sites (Fig. 7A).
Two of them, the proximal and the central one, are highly con-
served across species rat, mouse and man. To elucidate which
of the three DR1 motifs is necessary for the PPARa-dependent
induction of CAR additional truncation mutants were gener-
ated containing either none, one, two or all three of the DR1
motifs. As expected, luciferase transcription from a reporter
gene construct containing none of the DR1 motifs did not dif-
fer from the control vector and was not induced by the PPARa
agonist (not shown). Surprisingly, a 1 kb promoter fragment,
which contained the proximal conserved DR1 motif, but was
truncated at a unique PstI site immediately proximal of the
central DR1 motif also did not respond to the PPARa agonist
with an increase in transcription rate (Fig. 7B). By contrast,
transcription of a 1.2 kb construct that was truncated at a
BstXI site about 180 bp upstream of the central DR1 motif
and about 400 bp downstream of the distal DR1 motif
(Fig. 7B) was enhanced by the PPARa agonist to a similar ex-tent as the 1.9 kb construct, revealing that the region contain-
ing the central, conserved DR1 motif appears to be suﬃcient
and necessary to confer the PPARa-dependent induction of
CAR gene transcription, whereas the distal DR1 motif, which
is only present in the rat promoter but is lacking in the human
and mouse promoter appeared to be dispensable.
To exclude that essential promoter sequences apart from the
DR1 motif were lost by the consecutive shortening of the pro-
moter, additional constructs were generated in which one of
the DR1 motifs was deleted selectively within the 1.9 kb pro-
moter fragment by site directed mutagenesis. Deletion of the
proximal or the distal DR1-motif did not aﬀect the PPARa-
dependent activation of the reporter gene transcription while
deletion of the central DR1 motif completely abrogated
the PPARa-dependent reporter gene induction (Fig. 7C). A
labeled oligonucleotide probe comprising the central DR1 motif
plus 12–13 nucleotides up- and downstream bound speciﬁcally
to nuclear extracts of hepatocytes (Fig. 7D). The binding was
completely abolished by a 100-fold excess of an unlabeled
oligonucleotide competitor. Speciﬁc binding of proteins to
the labelled oligonucleotide probe was also reduced if a 5-fold
molar excess of a plasmid containing the 1.9 kb promoter frag-
ment with the three DR1 motifs was included into the binding
reaction. Similarly binding was reduced when the plasmids
which contain a 1.9 kb promoter fragment lacking either the
proximal or distal DR1 motif were added to the binding
reaction. By contrast, a plasmid containing a 1.9 kb promoter
construct lacking the central DR1 motif reduced binding only
to a similar extent as a similar amount of vector DNA without
the promoter region and thus apparently did not compete spe-
ciﬁcally with the binding of the oligonucleotide probe further
supporting the relevance of the central DR1 motif. In order
to corroborate that the bands observed in hepatocyte nuclear
Fig. 6. Activation by WY14643 of the transcription of a reporter gene construct under the control of rat CAR promoter fragments. Hepatocytes
were cultured as described in the methods section. Immediately after seeding they were transfected with the reporter gene constructs by a modiﬁed
calcium phosphate method. Phenobarbital and the PPARa agonist WY14643 were added as indicated after 24 h and 48 h of culture, respectively.
After a total culture period of 72 h hepatocytes were harvested. Luciferase activity was determined in cell lysates. Values are means ± S.E.M. of
n P 3 independent experiments normalized to control activity. Statistics: Student’s t-test for paired samples: (a) signiﬁcantly higher than control,
P < 0.05.
N. Wieneke et al. / FEBS Letters 581 (2007) 5617–5626 5623extracts really represent PPARa-binding to the probe, addi-
tional experiments were performed with HEK293 cells in
which rPPARa had been transiently overexpressed (Fig. 7E).
Western blot analysis of nuclear extracts of non-transfected
HEK293 cells revealed a weak band at about 50 kDa which
was markedly enhanced in nuclear extracts of cells transiently
transfected with an expression vector containing the translated
region of a PPARa cDNA. In an EMSA, a single shift band
was observed with nuclear extracts of HEK293 transfected
with the control vector. This band was much more pronounced
in cells transfected with a vector containing the translated re-
gion of the rat PPARa gene. It migrated at a position similar
to the upper band observed with hepatocyte nuclear extracts.
Taken together the data indicate that the central DR1 motif
is necessary and probably suﬃcient to confer the PPARa-
dependent activation of the CAR promoter.
3.4. Physiological signiﬁcance of PPARa-dependent CAR
induction
Recently it was reported that the fasting-induced increase in
CAR expression might depend on an adrenaline and cAMP-
dependent induction of PGC1a, which binds together with
HNF4a to a conserved sequence element in the proximal
CAR promoter. However, although the fasting-dependent
induction of CAR target genes was abolished in livers of ani-
mals lacking HNF4a the induction of CAR itself was blunted,
yet not abolished [6]. In our current study with rat hepatocytes,
in contrast to PPARa agonists neither adrenaline nor another
cAMP-elevating hormone, glucagon, increased CAR mRNA
or reporter gene activity under control of a 1.9 kb promoter
fragment that contained all elements that had been identiﬁedby Ding et al. to be relevant for cAMP-dependent induction
in mice (not shown). Species diﬀerences and diﬀerences in the
protocol for hepatocyte isolation and cultivation might explain
part of this discrepancy; in addition the majority of the exper-
iments performed by Ding et al. were carried out in tumor cells
rather than hepatocytes. Although this previous study clearly
showed that HNF4a is essential for basal CAR-expression
and modulation of HNF4a activity contributed to the fasting
adaptation of CAR expression, current data in rat hepatocytes
together with the experiments in PPARa-deﬁcient mice imply
that a PPARa-dependent increase in CAR expression is
needed to get a full response to starvation. Possibly PPARa
activation and the fasting-dependent increase in cAMP act in
parallel.
A glucocorticoid response element has previously been
described in the far upstream region of the human CAR
promoter [24]. Glucocorticoids have been shown to increase
CAR expression in human hepatocytes [25] and to potentiate
the induction of CAR-dependent genes including CYP2B
in human, mouse and rat hepatocytes [26]. Since glucocorti-
coid levels are increased during fasting, this might be an
additional mechanism by which fasting enhances CAR expres-
sion.
In accordance with our current ﬁnding, various conditions
that lead to an increase in plasma free fatty acid concentrations
have been shown to increase CAR mRNA in mice. Thus apart
from fasting an increase in free fatty acids in db/db mice led to
a CAR induction [27]. In addition, induction of a number of
CAR-dependent genes has been shown to be increased in insu-
lin-resistant mouse models with increased levels of plasma free
fatty acids [28].
Fig. 7. Identiﬁcation of a DR1 motif in the rat CAR promoter as potential target for the PPARa-dependent induction of CAR. (A) Positions of the
putative DR1 motifs in the CAR gene promoter are shown underlined and bold. A PstI site immediately proximal to the central DR1 motif that was
used to generate the contruct pGL3rCAR1.0 is shown in bold italic. (B) Hepatocytes were cultured as described in the methods section, except, that
insulin concentration was reduced to 0.5 nM after the initial adherence phase. Immediately after seeding they were transfected with the reporter gene
constructs by a modiﬁed calcium phosphate method. Phenobarbital and the PPARa agonist WY14643 were added as indicated after 24 h and 48 h of
culture, respectively. After a total culture period of 72 h hepatocytes were harvested. Luciferase activity was determined in cell lysates. (C)
Hepatocytes were cultured as in B, however, they were transfected with reporter gene constructs in which one of each of the DR1 motifs had been
eliminated selectively. Values are means ± S.E.M. of n P 3 independent experiments normalized to control activity. Statistics: Student’s t-test for
paired samples: (a) signiﬁcantly higher than control, P < 0.05. (D) Hepatocyte nuclear extracts (5 lg protein) were incubated with a labelled probe
comprising the central DR1 motif plus 12–13 nucleotides up- and downstream. Binding was competed with an 100-fold excess of unlabelled probe
(competitor) or a 5-fold molar excess of plasmids containing no promoter fragment (pGL-basic), a 1.9 kb promoter fragment with all three DR1
motifs (CAR 1.9 kb) or promoter fragments in which either the proximal (D-DR1 prox), central (D-DR1 cent) or distal (D-DR1 dist) DR1 motif was
deleted as indicated. The intensity of the two shift bands that are marked by the arrowheads were quantiﬁed densitometrically. A representative of
three independent experiments is shown. (E) Nuclear extracts (5 lg protein) of HEK293 cells transiently transfected with either pcDNA3 (pcDNA
control) or pcDNA3 containing the translated region of the rat PPARa gene (pcDNA-rPPARa) were incubated with a labelled probe comprising the
central DR1 motif plus 12–13 nucleotides up- and downstream. Binding was competed with an 100-fold excess of unlabelled probe. PPARa
expression was monitored by Western blot analysis.
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Fig. 7 (continued)
N. Wieneke et al. / FEBS Letters 581 (2007) 5617–5626 5625In conclusion, the newly discovered PPARa-dependent
induction of CAR via a conserved DR1 motif appears to be
of high physiological signiﬁcance both in the control of energy
homeostasis and xenobiotic metabolism.
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